Physician profile
Keith Swanson
NPI 1508952862
$6,600.41
in general payments reported to CMS, 2019-2025
10 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,719 · 2020: $16.12 · 2021: $15.81 · 2022: $42.09 · 2023: $393 · 2024: $250 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $5,639.48 | 2019-2025 | |
| Tactile Systems Technology INC | $314.94 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Organogenesis INC. | $187.54 | 2023-2025 | Puraply, Affinity |
| Smith+Nephew, INC. | $172.78 | 2021-2024 | Grafix Pl, Collagenase Santyl, Regranex |
| Next Science LLC | $75.91 | 2023-2024 | Blastx, Xperience, Surgx |
| Janssen Pharmaceuticals, INC | $63.96 | 2019 | |
| Integra Lifesciences Corporation | $49.63 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $42.09 | 2022 | |
| Kerecis Limited | $39.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $15.08 | 2023 | V.A.C. Dermatac, Snap, Promogran Prisma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.